Avicanna: Funding, Investors & Team (Sep 2026)
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis products. It employs a system based on data and experiments to present highly developed cannabinoid solutions in various product categories such as API, medical, pharmaceutical, and derma cosmetics. With vertical integration and a global presence, Avicanna is determined to harness the findings of scientific research on cannabis-based products with the aid of its internal research platforms and partnerships with renowned research institutions worldwide. Established in 2016, the company has its headquarters in Toronto, Ontario, Canada.
Avicanna has raised $8.6M across 10 funding rounds on record, the most recent an undisclosed round of $430k announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avicanna Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Avicanna Funding Rounds
1 of 10 rounds was announced without a disclosed amount and is excluded from the total.
Avicanna raised $910k in an undisclosed round announced in Mar 2023.
3 months later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
2 months later, an undisclosed round of $1.5M was announced in Aug 2023.
4 months later, an undisclosed round of $660k was announced in Dec 2023.
4 months later, an undisclosed round of $1.5M was announced in Apr 2024.
1.3 years later, an undisclosed round of $730k was announced in Jul 2025.
7 months later, an undisclosed round of $1.1M was announced in Feb 2026.
4 months later, an undisclosed round of $430k was announced in Jun 2026.
Avicanna Founders and Leadership Team
Contact details for the Avicanna team: 2 of 2 have an email address on file.
Start 14-day free trial →Avicanna Funding Compared to Other Biotechnology Startups
Avicanna's latest round of $430k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avicanna in Biotechnology and Toronto
Companies Similar to Avicanna
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Resverlogix Corporation, a biopharmaceutical company, focuses on the development of novel therapeutics in…
Avicanna Funding FAQs
What does Avicanna do?
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis products. It employs a system based on data and experiments to present highly developed cannabinoid solutions in various product categories such as API, medical, pharmaceutical, and derma cosmetics. With vertical integration and a global presence, Avicanna is determined to harness the findings of scientific research on cannabis-based products with the aid of its internal research platforms and partnerships with renowned research institutions worldwide. Established in 2016, the company has its headquarters in Toronto, Ontario, Canada.
How much funding has Avicanna raised?
Avicanna has raised $8.6M across 10 rounds on record. The most recent is an undisclosed round of $430k announced in Jun 2026.
When did Avicanna last raise funding?
Avicanna's most recent funding round on record is an undisclosed round of $430k, announced in Jun 2026.
Who founded Avicanna?
FundedIQ lists Setu Purohit (Founder) at Avicanna.
Who is the CEO of Avicanna?
Aras Azadian is listed as CEO at Avicanna.
Where is Avicanna headquartered?
Avicanna is based in Toronto, Ontario, Canada.
How many employees does Avicanna have?
Avicanna is in the 51-100 employee band.
How does Avicanna's funding compare to other Biotechnology startups?
Avicanna's latest round of $430k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Avicanna Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avicanna is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.